245 related articles for article (PubMed ID: 15998297)
1. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
3. Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.
Suzuki K; Vanier MT; Coetzee T; Popko B
Neurochem Res; 1999 Apr; 24(4):471-4. PubMed ID: 10227678
[TBL] [Abstract][Full Text] [Related]
4. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
5. Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in twitcher mouse brain.
Taniike M; Marcus JR; Nishigaki T; Fujita N; Popko B; Suzuki K; Suzuki K
J Neurosci Res; 1998 Feb; 51(4):536-40. PubMed ID: 9514207
[TBL] [Abstract][Full Text] [Related]
6. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
Coetzee T; Dupree JL; Popko B
J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
[TBL] [Abstract][Full Text] [Related]
7. UDP-galactose-ceramide galactosyltransferase in rat brain myelin subfractions during development.
Koul O; Chou KH; Jungalwala FB
Biochem J; 1980 Mar; 186(3):959-69. PubMed ID: 6772157
[TBL] [Abstract][Full Text] [Related]
8. Galactolipids are molecular determinants of myelin development and axo-glial organization.
Marcus J; Popko B
Biochim Biophys Acta; 2002 Dec; 1573(3):406-13. PubMed ID: 12417425
[TBL] [Abstract][Full Text] [Related]
9. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in glycolipid synthesizing enzymes in the brain of a myelin-deficient mutant Wistar rat.
Hof L; Csiza CK
J Neurochem; 1982 Nov; 39(5):1434-9. PubMed ID: 6214615
[TBL] [Abstract][Full Text] [Related]
11. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide.
Schaeren-Wiemers N; van der Bijl P; Schwab ME
J Neurochem; 1995 Nov; 65(5):2267-78. PubMed ID: 7595516
[TBL] [Abstract][Full Text] [Related]
12. Effects of galactolipid elimination on oligodendrocyte development and myelination.
Marcus J; Dupree JL; Popko B
Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
[TBL] [Abstract][Full Text] [Related]
13. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease.
Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
J Neurol Sci; 1990 Dec; 100(1-2):124-30. PubMed ID: 2128519
[TBL] [Abstract][Full Text] [Related]
14. UDP-galactose:ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum.
Sprong H; Kruithof B; Leijendekker R; Slot JW; van Meer G; van der Sluijs P
J Biol Chem; 1998 Oct; 273(40):25880-8. PubMed ID: 9748263
[TBL] [Abstract][Full Text] [Related]
15. UDP-galactose: ceramide galactosyltransferase of rat central nervous system myelin during development.
Koul O; Jungalwala FB
Neurochem Res; 1986 Feb; 11(2):231-9. PubMed ID: 3084981
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
[TBL] [Abstract][Full Text] [Related]
17. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin.
Eckhardt M; Yaghootfam A; Fewou SN; Zöller I; Gieselmann V
Biochem J; 2005 May; 388(Pt 1):245-54. PubMed ID: 15658937
[TBL] [Abstract][Full Text] [Related]
18. Regulation of UDP-galactose:ceramide galactosyltransferase and UDP-glucose:ceramide glucosyltransferase after crush and transection nerve injury.
Costantino-Ceccarini E; Poduslo JF
J Neurochem; 1989 Jul; 53(1):205-11. PubMed ID: 2524552
[TBL] [Abstract][Full Text] [Related]
19. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.
Zöller I; Meixner M; Hartmann D; Büssow H; Meyer R; Gieselmann V; Eckhardt M
J Neurosci; 2008 Sep; 28(39):9741-54. PubMed ID: 18815260
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of UDP-galactose: ceramide galactosyltransferase in myelin and oligodendroglial cells of rat brain.
Roussel G; Nussbaum JL; Espinosa de los Monteros A; Neskovic NM
J Neurocytol; 1987 Feb; 16(1):85-92. PubMed ID: 3108463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
